Lista de obras - Jolanta Krajewska - Dominio Público Uruguay

131-I MIBG therapy of malignant pheochromocytoma and paraganglioma tumors - a single center study

artículo científico publicado en 2018

131I-MIBG therapy in the treatment of pheochromocytoma in children--own experiences

artículo científico publicado en 2008

A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg Per Day Compared with the Cabozantinib Capsule at 140 mg Per Day in Patients with Progressive, Metastatic Medullary Thyroid Cancer

artículo científico publicado en 2022

A registry-based study of thyroid paraganglioma: histological and genetic characteristics

artículo científico publicado en 2015

A two miRNA classifier differentiates follicular thyroid carcinomas from follicular thyroid adenomas.

artículo científico publicado en 2014

Advances in small molecule therapy for treating metastatic thyroid cancer.

artículo científico publicado en 2017

Age at diagnosis and gender modify the risk of 9q22 and 14q13 polymorphisms for papillary thyroid carcinoma.

artículo científico publicado en 2017

An internist's approach to cancer diseases based on the model of thyroid cancer treated with tyrosine kinase inhibitors.

artículo científico publicado en 2016

BRAFV600E-Associated Gene Expression Profile: Early Changes in the Transcriptome, Based on a Transgenic Mouse Model of Papillary Thyroid Carcinoma

artículo científico publicado en 2015

Cabozantinib for the treatment of progressive metastatic medullary thyroid cancer

artículo científico publicado en 2015

Childhood thyroid carcinoma — single-centre experience

artículo científico publicado en 2021

Coexistence of Promoter Mutations and the V600E Alteration and Its Impact on Histopathological Features of Papillary Thyroid Carcinoma in a Selected Series of Polish Patients

artículo científico publicado en 2018

Concentrations of Selected Adipokines, Interleukin-6, and Vitamin D in Patients with Papillary Thyroid Carcinoma in Respect to Thyroid Cancer Stages

artículo científico publicado en 2018

Corrigendum: Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations

artículo científico publicado en 2017

Current Advances in Thyroid Cancer Management. Are We Ready for the Epidemic Rise of Diagnoses? ⬇️

artículo científico publicado en 2017

Current status of the prognostic molecular markers in medullary thyroid carcinoma

artículo científico publicado en 2020

Current treatment options for gastroenteropancreatic neuroendocrine tumors with a focus on the role of lanreotide

artículo científico publicado en 2017

Diagnosis and treatment of thyroid cancer in adult patients — Recommendations of Polish Scientific Societies and the National Oncological Strategy. 2022 Update [Diagnostyka i leczenie raka tarczycy u chorych dorosłych — Rekomendacje Polskich Tow

artículo científico publicado en 2022

Diagnostics and Treatment of Thyroid Carcinoma

artículo científico publicado en 2016

Diagnostics and treatment of differentiated thyroid carcinoma in children - Guidelines of Polish National Societies.

artículo científico publicado en 2016

Differences in Gene Expression Profile of Primary Tumors in Metastatic and Non-Metastatic Papillary Thyroid Carcinoma-Do They Exist? ⬇️

artículo científico publicado en 2020

Differences in Gene-Gene Interactions in Graves' Disease Patients Stratified by Age of Onset.

artículo científico publicado en 2016

Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations.

artículo científico publicado en 2017

Drug safety evaluation of lenvatinib for thyroid cancer.

artículo científico publicado en 2015

Dynamic risk stratification in the follow-up of thyroid cancer

artículo científico publicado en 2017

Early Diagnosis of Low-Risk Papillary Thyroid Cancer Results Rather in Overtreatment Than a Better Survival

artículo científico publicado en 2020

Efficacy of lenvatinib in treating thyroid cancer.

artículo científico publicado en 2016

Emerging multikinase inhibitors for the treatment of differentiated thyroid cancer: whom to treat?

artículo científico publicado en 2016

European perspective on the use of molecular tests in the diagnosis and therapy of thyroid neoplasms

scientific article published on 01 February 2020

Fosbretabulin tromethamine in the treatment of thyroid cancer

artículo científico publicado en 2016

Gene Expression (mRNA) Markers for Differentiating between Malignant and Benign Follicular Thyroid Tumours

artículo científico publicado en 2017

Germinal mutations of RET, SDHB, SDHD, and VHL genes in patients with apparently sporadic pheochromocytomas and paragangliomas

artículo científico publicado en 2010

Guidelines of Polish National Societies Diagnostics and Treatment of Thyroid Carcinoma. 2018 Update

artículo científico publicado en 2018

HLA Status in Patients with Chronic Spontaneous Urticaria

artículo científico publicado en 2010

Heterogeneity of Thyroid Cancer

artículo científico publicado en 2018

Impact of the Tumor Microenvironment on the Gene Expression Profile in Papillary Thyroid Cancer

scientific article published on 22 April 2020

Important considerations when choosing pharmacotherapy for Graves' disease in children.

artículo científico publicado en 2019

Lenvatinib for the treatment of radioiodine-refractory follicular and papillary thyroid cancer

artículo científico publicado en 2014

Managing tyrosine kinase inhibitors side effects in thyroid cancer

artículo científico publicado en 2017

Meeting abstracts from the Annual Conference on Hereditary Cancers 2015: Szczecin, Poland. 24-25 September, 2015.

artículo científico publicado en 2017

Molecular classification of pituitary adenomas: in search for criteria useful for high-throughput studies

artículo científico publicado en 2016

Multikinase Inhibitors for the Treatment of Progressive, Metastatic Medullary Thyroid Cancer - An Evolving Paradigm

artículo científico publicado en 2014

Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study

artículo científico publicado en 2019

Novel TG-FGFR1 and TRIM33-NTRK1 transcript fusions in papillary thyroid carcinoma

artículo científico publicado en 2019

Novel therapies for thyroid cancer

artículo científico publicado en 2014

Ongoing risk stratification for differentiated thyroid cancer (DTC) - stimulated serum thyroglobulin (Tg) before radioiodine (RAI) ablation, the most potent risk factor of cancer recurrence in M0 patients.

artículo científico publicado en 2016

Postoperative Radioiodine Treatment within 9 Months from Diagnosis Significantly Reduces the Risk of Relapse in Low-Risk Differentiated Thyroid Carcinoma

scientific article published on 05 September 2019

Radioactive iodine (RAI) treatment of hyperthyroidism is safe in patients with Graves' orbitopathy--a prospective study

scientific article published on 01 January 2014

Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi

artículo científico publicado en 2010

Ratio of proliferation markers and HSP90 gene expression as a predictor of pathological complete response in breast cancer neoadjuvant chemotherapy

artículo científico publicado en 2017

Recent advances in precision medicine for the treatment of medullary thyroid cancer

artículo científico publicado en 2021

Recombinant human thyrotropin preparation for adjuvant radioiodine treatment in children and adolescents with differentiated thyroid cancer

scientific article published on 30 September 2015

Safety and efficacy of two starting doses of vandetanib in advanced medullary thyroid cancer

scientific article published on 01 February 2019

Somatic mutation profiling of follicular thyroid cancer by next generation sequencing

artículo científico publicado en 2016

Sorafenib for the treatment of thyroid cancer: an updated review.

artículo científico publicado en 2015

TERT Promoter Mutations and Their Impact on Gene Expression Profile in Papillary Thyroid Carcinoma

scientific article published on 17 June 2020

The Risk of Relapse in Papillary Thyroid Cancer (PTC) in the Context of BRAFV600E Mutation Status and Other Prognostic Factors

artículo científico publicado en 2015

The assessment of side effects of tyrosine kinase inhibitors (TKI) applied in patients with advanced thyroid cancer (TC) - one centre experience

artículo científico publicado en 2013

The prevalence of somatic RAS mutations in medullary thyroid cancer - a Polish population study

artículo científico publicado en 2015

The role of FDG-PET in localization of recurrent lesions of differentiated thyroid cancer (DTC) in patients with asymptomatic hyperthyroglobulinemia in a real clinical practice

artículo científico publicado en 2016

The role of postoperative adjuvant radiotherapy in the local control in medullary thyroid carcinoma

scientific article published on 01 November 2019

Therapeutic Strategy in Low-Risk Papillary Thyroid Carcinoma - Long-Term Results of the First Single-Center Prospective Non-Randomized Trial Between 2011 and 2015

artículo científico publicado en 2021

Thyroid diseases in pregnancy: guidelines of the Polish Society of Endocrinology [Choroby tarczycy w ciąży: zalecenia postępowania Polskiego Towarzystwa Endokrynologicznego]

artículo científico publicado en 2021

Thyroid remnant ablation with radioiodine activity of 30, 60, and 100 mCi in patients with differentiated thyroid cancer - a prospective comparison of long-term outcomes

artículo científico publicado en 2022

Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.

artículo científico publicado en 2007

Unsupervised analysis of follicular thyroid tumours transcriptome by oligonucleotide microarray gene expression profiling

artículo científico publicado en 2013

[Completion total thyroidectomy in children with differentiated thyroid cancer]

artículo científico publicado en 2006

[Diagnosis and treatment of thyroid cancer - Polish guidelines].

artículo científico publicado en 2010

[Indications for surgery of thyroid cancer based on bioptate molecular examination].

artículo científico publicado en 2006

[Optimization of 131I ablation in patients with differentiated thyroid carcinoma: comparison of early outcomes of treatment with 100 mCi versus 60 mCi]

artículo científico publicado en 2006

[Recombinant human TSH stimulation in radioiodine treatment of disseminated differentiated thyroid cancer--update of current and our own experiences]

artículo científico publicado en 2006

Lista de obras de Jolanta Krajewska

131-I MIBG therapy of malignant pheochromocytoma and paraganglioma tumors - a single center study

131I-MIBG therapy in the treatment of pheochromocytoma in children--own experiences

A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg Per Day Compared with the Cabozantinib Capsule at 140 mg Per Day in Patients with Progressive, Metastatic Medullary Thyroid Cancer

A registry-based study of thyroid paraganglioma: histological and genetic characteristics

A two miRNA classifier differentiates follicular thyroid carcinomas from follicular thyroid adenomas.

Advances in small molecule therapy for treating metastatic thyroid cancer.

Age at diagnosis and gender modify the risk of 9q22 and 14q13 polymorphisms for papillary thyroid carcinoma.

An internist's approach to cancer diseases based on the model of thyroid cancer treated with tyrosine kinase inhibitors.

BRAFV600E-Associated Gene Expression Profile: Early Changes in the Transcriptome, Based on a Transgenic Mouse Model of Papillary Thyroid Carcinoma

Cabozantinib for the treatment of progressive metastatic medullary thyroid cancer

Childhood thyroid carcinoma — single-centre experience

Coexistence of Promoter Mutations and the V600E Alteration and Its Impact on Histopathological Features of Papillary Thyroid Carcinoma in a Selected Series of Polish Patients

Concentrations of Selected Adipokines, Interleukin-6, and Vitamin D in Patients with Papillary Thyroid Carcinoma in Respect to Thyroid Cancer Stages

Corrigendum: Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations

Current Advances in Thyroid Cancer Management. Are We Ready for the Epidemic Rise of Diagnoses? ⬇️

Current status of the prognostic molecular markers in medullary thyroid carcinoma

Current treatment options for gastroenteropancreatic neuroendocrine tumors with a focus on the role of lanreotide

Diagnosis and treatment of thyroid cancer in adult patients — Recommendations of Polish Scientific Societies and the National Oncological Strategy. 2022 Update [Diagnostyka i leczenie raka tarczycy u chorych dorosłych — Rekomendacje Polskich Tow

Diagnostics and Treatment of Thyroid Carcinoma

Diagnostics and treatment of differentiated thyroid carcinoma in children - Guidelines of Polish National Societies.

Differences in Gene Expression Profile of Primary Tumors in Metastatic and Non-Metastatic Papillary Thyroid Carcinoma-Do They Exist? ⬇️

Differences in Gene-Gene Interactions in Graves' Disease Patients Stratified by Age of Onset.

Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations.

Drug safety evaluation of lenvatinib for thyroid cancer.

Dynamic risk stratification in the follow-up of thyroid cancer

Early Diagnosis of Low-Risk Papillary Thyroid Cancer Results Rather in Overtreatment Than a Better Survival

Efficacy of lenvatinib in treating thyroid cancer.

Emerging multikinase inhibitors for the treatment of differentiated thyroid cancer: whom to treat?

European perspective on the use of molecular tests in the diagnosis and therapy of thyroid neoplasms

Fosbretabulin tromethamine in the treatment of thyroid cancer

Gene Expression (mRNA) Markers for Differentiating between Malignant and Benign Follicular Thyroid Tumours

Germinal mutations of RET, SDHB, SDHD, and VHL genes in patients with apparently sporadic pheochromocytomas and paragangliomas

Guidelines of Polish National Societies Diagnostics and Treatment of Thyroid Carcinoma. 2018 Update

HLA Status in Patients with Chronic Spontaneous Urticaria

Heterogeneity of Thyroid Cancer

Impact of the Tumor Microenvironment on the Gene Expression Profile in Papillary Thyroid Cancer

Important considerations when choosing pharmacotherapy for Graves' disease in children.

Lenvatinib for the treatment of radioiodine-refractory follicular and papillary thyroid cancer

Managing tyrosine kinase inhibitors side effects in thyroid cancer

Meeting abstracts from the Annual Conference on Hereditary Cancers 2015: Szczecin, Poland. 24-25 September, 2015.

Molecular classification of pituitary adenomas: in search for criteria useful for high-throughput studies

Multikinase Inhibitors for the Treatment of Progressive, Metastatic Medullary Thyroid Cancer - An Evolving Paradigm

Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study

Novel TG-FGFR1 and TRIM33-NTRK1 transcript fusions in papillary thyroid carcinoma

Novel therapies for thyroid cancer

Ongoing risk stratification for differentiated thyroid cancer (DTC) - stimulated serum thyroglobulin (Tg) before radioiodine (RAI) ablation, the most potent risk factor of cancer recurrence in M0 patients.

Postoperative Radioiodine Treatment within 9 Months from Diagnosis Significantly Reduces the Risk of Relapse in Low-Risk Differentiated Thyroid Carcinoma

Radioactive iodine (RAI) treatment of hyperthyroidism is safe in patients with Graves' orbitopathy--a prospective study

Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi

Ratio of proliferation markers and HSP90 gene expression as a predictor of pathological complete response in breast cancer neoadjuvant chemotherapy

Recent advances in precision medicine for the treatment of medullary thyroid cancer

Recombinant human thyrotropin preparation for adjuvant radioiodine treatment in children and adolescents with differentiated thyroid cancer

Safety and efficacy of two starting doses of vandetanib in advanced medullary thyroid cancer

Somatic mutation profiling of follicular thyroid cancer by next generation sequencing

Sorafenib for the treatment of thyroid cancer: an updated review.

TERT Promoter Mutations and Their Impact on Gene Expression Profile in Papillary Thyroid Carcinoma

The Risk of Relapse in Papillary Thyroid Cancer (PTC) in the Context of BRAFV600E Mutation Status and Other Prognostic Factors

The assessment of side effects of tyrosine kinase inhibitors (TKI) applied in patients with advanced thyroid cancer (TC) - one centre experience

The prevalence of somatic RAS mutations in medullary thyroid cancer - a Polish population study

The role of FDG-PET in localization of recurrent lesions of differentiated thyroid cancer (DTC) in patients with asymptomatic hyperthyroglobulinemia in a real clinical practice

The role of postoperative adjuvant radiotherapy in the local control in medullary thyroid carcinoma

Therapeutic Strategy in Low-Risk Papillary Thyroid Carcinoma - Long-Term Results of the First Single-Center Prospective Non-Randomized Trial Between 2011 and 2015

Thyroid diseases in pregnancy: guidelines of the Polish Society of Endocrinology [Choroby tarczycy w ciąży: zalecenia postępowania Polskiego Towarzystwa Endokrynologicznego]

Thyroid remnant ablation with radioiodine activity of 30, 60, and 100 mCi in patients with differentiated thyroid cancer - a prospective comparison of long-term outcomes

Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.

Unsupervised analysis of follicular thyroid tumours transcriptome by oligonucleotide microarray gene expression profiling

[Completion total thyroidectomy in children with differentiated thyroid cancer]

[Diagnosis and treatment of thyroid cancer - Polish guidelines].

[Indications for surgery of thyroid cancer based on bioptate molecular examination].

[Optimization of 131I ablation in patients with differentiated thyroid carcinoma: comparison of early outcomes of treatment with 100 mCi versus 60 mCi]

[Recombinant human TSH stimulation in radioiodine treatment of disseminated differentiated thyroid cancer--update of current and our own experiences]